<?xml version="1.0" encoding="UTF-8"?>
<p class="p">In terms of Fe
 <sup class="sup">3+</sup> reducing activity at selected dose levels of 5–25 µg/mL, the EOs exhibited dose dependent reducing power activity. The RP
 <sub xmlns="http://www.w3.org/1999/xhtml">50</sub> values in different seasons for all the EOs were observed in the order of Spring: ACPGREO &gt; ACPGLEO &gt; ACBTREO &gt; ACBTLEO &gt; ACPNLEO &gt; ACPNREO; Summer ACBTREO &gt; ACPGREO &gt; ACPNREO &gt; ACBTLEO &gt; ACPNLEO &gt; ACPGLEO; Autumn ACPGREO &gt; ACBTREO &gt; ACPNREO &gt; ACBTLEO &gt; ACPNLEO &gt; ACPGLEO; Winter ACPGREO &gt; ACBTREO &gt; ACBTLEO &gt; ACPNLEO &gt; ACPNREO &gt; ACPGLEO. However, the RP
 <sub xmlns="http://www.w3.org/1999/xhtml">50</sub> of standards were observed in the order gallic acid (RP
 <sub xmlns="http://www.w3.org/1999/xhtml">50</sub> = 56.07 µg/mL) &gt; catechin (RP
 <sub xmlns="http://www.w3.org/1999/xhtml">50</sub> = 71.74 µg/mL) (
 <xref ref-type="table" rid="medicines-04-00081-t005" class="xref">Table 5</xref>).
</p>
